Cancer Biopsy Market
According to Intent Market Research, the Cancer Biopsy Market is expected to grow from USD 21.3 billion in 2023 at a CAGR of 10.0% to touch USD 41.6 billion by 2030. The Cancer Biopsy Market is dominated by key players such as Roche, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Abbott Laboratories, Qiagen, Guardant Health, Exact Sciences Corporation, Foundation Medicine, Veracyte, Neogenomics, Siemens Healthineers, GE Healthcare, Philips Healthcare, Agilent Technologies.